These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10327982)

  • 1. Underuse of aspirin for secondary prevention of vascular disease.
    Mollison LC; James-Wallace MJ; Kirke AB; Stein GR; Jamrozik KD
    Med J Aust; 1999 Apr; 170(7):339, 341. PubMed ID: 10327982
    [No Abstract]   [Full Text] [Related]  

  • 2. Underuse of antiplatelets and inappropriate use.
    Naunton M; Duyvendak M
    Eur J Clin Pharmacol; 2006 Jan; 62(1):81-2; author reply 79-80. PubMed ID: 16320046
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment for the secondary prevention of stroke in older patients: the influence of dementia status.
    Moroney JT; Tseng CL; Paik MC; Mohr JP; Desmond DW
    J Am Geriatr Soc; 1999 Jul; 47(7):824-9. PubMed ID: 10404926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The specificity of prescription patterns in secondary stroke prevention.
    Bellelli G; Trabucchi M
    J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):512; author reply 512. PubMed ID: 14966188
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of aspirin for primary and secondary cardiovascular disease prevention in the United States, 2011-2012.
    Mainous AG; Tanner RJ; Shorr RI; Limacher MC
    J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25023071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus and peripheral vascular disease: is aspirin effective in preventing vascular events?
    Cimminiello C; Milani M
    Diabetologia; 1996 Nov; 39(11):1402-4. PubMed ID: 8933012
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictors and time trends in clopidogrel and proton pump inhibitor coprescription with low-dose acetylsalicylic acid.
    Cea Soriano L; Bueno H; Johansson S; García Rodríguez LA
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):463-9. PubMed ID: 22298501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development Group.
    Eccles M; Freemantle N; Mason J
    BMJ; 1998 Apr; 316(7140):1303-9. PubMed ID: 9554904
    [No Abstract]   [Full Text] [Related]  

  • 9. Contemporary audit of antiplatelet therapy prescribing patterns following coronary artery bypass grafting.
    Wei D; Wang TKM
    N Z Med J; 2019 Jul; 132(1498):100-104. PubMed ID: 31295243
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of cardiovascular disease: risks and benefits of aspirin.
    Buring JE; Hennekens CH
    J Gen Intern Med; 1990; 5(5 Suppl):S54-7. PubMed ID: 2231066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke. Medical therapy in patients with carotid artery stenosis.
    Goldstein LB; Bonito AJ; Matchar DB; Duncan PW; Samsa GP
    Stroke; 1996 Sep; 27(9):1473-8. PubMed ID: 8784115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the evidence on aspirin in diabetes mellitus. Gemini or Libra; lumping or splitting; surrogate or hard; low or high; interventionist or nihilist.
    Yudkin JS
    Diabetologia; 1996 Nov; 39(11):1407-8. PubMed ID: 8933014
    [No Abstract]   [Full Text] [Related]  

  • 13. Aspirin, clopidogrel, and the surgeon.
    Patel PA; Fleisher LA
    Adv Surg; 2014; 48():211-22. PubMed ID: 25293617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of patients with acute myocardial infarction and end-stage renal disease.
    Conti CR
    J Am Coll Cardiol; 2003 Jul; 42(2):209-10. PubMed ID: 12875752
    [No Abstract]   [Full Text] [Related]  

  • 15. Missed opportunities for secondary prevention of cerebrovascular disease in elderly British men from 1999 to 2005: a population-based study.
    Ramsay SE; Whincup PH; Wannamethee SG; Papacosta O; Lennon L; Thomas MC; Morris RW
    J Public Health (Oxf); 2007 Sep; 29(3):251-7. PubMed ID: 17584949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A 100 years of aspirin: a drug with a future?].
    Sánchez García P
    An R Acad Nac Med (Madr); 1997; 114(1):157-63; discussion 164-7. PubMed ID: 9324911
    [No Abstract]   [Full Text] [Related]  

  • 17. Recommended use of aspirin and other antiplatelet medications among adults--National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey, United States, 2005-2008.
    George MG; Tong X; Sonnenfeld N; Hong Y;
    MMWR Suppl; 2012 Jun; 61(2):11-8. PubMed ID: 22695458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
    Stafford RS; Monti V; Ma J
    PLoS Med; 2005 Dec; 2(12):e353. PubMed ID: 16277554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Secondary prevention of ischemic stroke: aspirin or ticlopidine].
    Zambrana JL; Díez F; Delgado M; Salas J
    Med Clin (Barc); 1998 Oct; 111(13):518. PubMed ID: 9859073
    [No Abstract]   [Full Text] [Related]  

  • 20. Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people.
    Ardoino I; Rossio R; Di Blanca D; Nobili A; Pasina L; Mannucci PM; Peyvandi F; Franchi C;
    Br J Clin Pharmacol; 2017 Nov; 83(11):2528-2540. PubMed ID: 28722184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.